Choosing the Best Treatment for Hair Loss
February 16th, 2010 admin
Topics:
The main existing approaches to combating hair loss include a) antiandrogen treatment, which addresses the leading cause of hereditary baldness – dihydrotestosterone’s (DHT) negative effects on hair follicles and b) promoting new hair growth with hair growth stimulants. Hereditary hair loss in both men and women is caused by DHT attacking our hair follicles, leading to their miniaturisation and eventual death. Propecia (generic name finasteride) is the only FDA-approved antiandrogen for treating hair …
Related Posts
Propecia is the only FDA-approved, oral drug for treating male pattern baldness. It appears to be the most powerful treatment currently available for treating hair loss in men. Clinical evidence largely supports this claim. The sole active ingredient of Propecia is called finasteride and it works by inhibiting the conversion of testosterone into follicle-...
Rogaine was the first medicinal product in history approved by a major national health supervisory authority – the FDA (the US Food and Drug Administration) to treat male pattern baldness. To this day it is the only clinically-proven, topical method of treating hereditary hair loss that can be used by both men and women. Minoxidil is the sole...
Flutamide is a non-steroid antiandrogen binding to androgen receptors and thus competing for this place with follicle-harming dihydrotestosterone (DHT). It is a very powerful antiandrogen, available only by doctor’s prescription. Oral flutamide is used in women to treat hirsutism (excess body hair) and acne and in men to treat prostate cancer....
Bimatoprost, a glaucoma treatment that has been recently approved for lengthening and thickening eyelashes (Latisse) is currently being studied for its topical use in promoting hair growth in patients affected by hereditary hair loss. Preliminary reports from laboratory tests with human hair sound encouraging. It has been reported that the topical...
For over a decade, balding men have had two clinically proven options for treating their hair loss medically. !n 1988, Rogaine (minoxidil) 2% Topical Solution for Men launched as a prescription medication. Men’s Rogaine 5% Extra Strength Solution was approved for over-the-counter use in 1997. That same year, the FDA also approved finasteride...
For over a decade, balding men have had two clinically proven options for treating their hair loss medically. !n 1988, Rogaine (minoxidil) 2% Topical Solution for Men launched as a prescription medication. Men’s Rogaine 5% Extra Strength Solution was approved for over-the-counter use in 1997. That same year, the FDA also approved finasteride...
This insightful article was written by “PanamaJimmy”, an active member of our hair loss forum and social community. I’ve seen lots of ads lately for a hair loss product called Provillus. They claim it has an FDA approved ingredient for regrowing hair. Is this product legit? Provillus does contain an FDA approved ingredient for hair...
Lexington International’s HairMax LaserComb is the latest FDA-approved remedy for promoting hair growth. It employs a technology that has been in use for several years to accelerate healing and hair growth after hair transplant surgery. There are other laser combs on the market that are less expensive than Lexington International’s HairMax, and...
Xandrox is one of the more popular generic topical applications for treating hair loss. It combines the benefits of the FDA-approved hair growth stimulant, minoxidil, with the assumed dihydrotestosterone (DHT) inhibitor, azelaic acid, in a single formula. There are dozens of other generic minoxidil applications that mimic this formula available on...
Bimatoprost, the main active ingredient of Allergan, a medication used to reduce intraocular pressure and thus control glaucoma, has been recently approved by the FDA for lengthening eyelashes. This new cosmetic formulation of bimatoprost is sold as Latisse. It is not uncommon that a drug’s unexpected side effects are utilised to treat other conditions,...
Related Tweets from Twitter
Related News from Digg
Leave a comment
| Trackback
